Mirxes Holding Company Limited (HKG:2629)

Revenue by Product

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Early Detection and Precision Multi-omics	23.59M
Early Detection and Precision Multi-omics Growth	0.47%
Infectious Diseases	3.52M
Infectious Diseases Growth	-60.96%

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Singapore	16.20M
Singapore Growth	-19.20%
China	9.27M
China Growth	18.94%
United States	571.17K
United States Growth	45.39%
Other Southeast Asia	476.05K
Other Southeast Asia Growth	36.69%
Philippines	114.49K
Philippines Growth	-94.26%
Indonesia	6.28K
Indonesia Growth	-99.49%
Other	469.11K
Other Growth	-11.86%